Genomic Medicine, HbF and Sickle Cell Anemia
Einstein/Montefiore Department of Medicine Grand Rounds
Thursday, October 04, 2012
8:00 AM: Forchheimer Medical Science Building 3rd Fl Lecture Hall
Speaker & Info
Martin Steinberg, MD
Professor of Medicine, Pediatrics, Pathology and Laboratory Medicine
Department of Medicine
Boston University School of Medicine
Center of Excellence in Sickle Cell Disease
Boston Medical Center
Repeated at 12:15 pm, Cherkasky Auditorium, Montefiore Medical Center
Dr. Martin H. Steinberg's research and clinical interests are focused on disorders of the red blood cell with a special emphasis on sickle cell disease and inherited disorders of hemoglobin. His current work focuses on genotype-phenotype relationahips in sickle cell diseases and thalessemia and the regulation of fetal hemoglobin. He and his staff also conduct clinical trials of innovative treatments for sickle cell disease. Dr. Steinberg has published more than 350 articles in his areas of interest and has written and edited three textbooks that focus on the basic science and clinical aspects of sickle cell disease and other disorders of the hemoglobin molecule.
Dr. Steinberg has served as a scientific consultant for the American Heart Association, FDA, HIH, NSF, Department of Veterans Affairs, Doris Duke Charitable Foundation, and for many countries in Europe and Asia. Additionally, he has served on the editorial boards of several journals. His current research is funded by the NIH.
Dr. Steinberg received his BA from Cornell University and his MD from Tufts University School of Medicine. His internship in Internal Medicine was on the Cornell Division of Bellvue Hospital Center in New York City and was followed by a medical residency and hematology fellowship at the Tufts-New England Medical Center in Boston. He was Professor of Medicine at the University of Mississippi and Associate Chief of Staff for Research at the Jackson Veterans Administration Hospital until 2000. He is a diplomat of the American Board of Internal Medicine in the subspecialty of Hematology, a member of the American Board of Internal Medicine Subspecialty Board of Hematology, a Fellow of the American Association for the Advancement of Science, and a member of the American Society for Clinical Investigation and of the Association of American Physicians.
Objectives - After attending this activity, participants will:
- Understand the general purpose and use of genetic association studies in medicine
- See how genetic association studies have expanded our understanding of sickle cell disease pathophysiology
- Understand how fetal hemoglobin levels differ among populations, are genetically controlled, modify the clinical aspects of sickle cell disease, and how fetal hemoglobin inducing agents are clinically important
Accreditation: Albert Einstein College of Medicine designates this educational activity for a maximum of 1 credit towards the AMA Physician's Recognition Award. Each physician should claim only those credits that he/she actually spent in the educational activity.
Department of Medicine (Division of Hematology)